New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Mangoceuticals, Inc.
MGRX
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

22M

Medical - Healthcare Information Services

Next Earning date - 07 Apr 2025

22M

Medical - Healthcare Information Services

Next Earning date - 07 Apr 2025

5.45USD

Shape0.62 ( 12.83%)
Market Closed (as of Feb 19, 20:48 EDT)
favorite-chart

Relative Strenght

96
favorite-chart

Volume Buzz

110%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

68%
OverviewChart

Quote Panel

Shape
Updated March 24, 2025
1W 23.20 % 1M 8.78 % 3M 70.23 % 1Y 57.04 %

Key Metrics

Shape

  • Market Cap

    22.16M

  • Shares Outstanding

    5.17M

  • Share in Float

    2.87M

  • Dividende

    0

  • Earning Date

    07 Apr 2025

  • Price Target

    4.46

  • Average Volume

    95775

  • Beta

    1.5100261

  • Range

    2.07-16.8

  • Industry

    Medical - Healthcare Information Services

  • Website

    https://www.mangorx.com

  • Sector

    Healthcare

Fundamentals

Shape

Relative Strength

Shape

MGRX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.04
vs -0.00

Q1.23

arrow
arrow

N/A

-0.14
vs -0.00

Q2.23

arrow
arrow

N/A

-0.14
vs -0.01

Q3.23

arrow
arrow

N/A

-1.65
vs -0.10

Q4.23

arrow
arrow

N/A

-0.12
vs -0.04

Q1.24

arrow
arrow

N/A

-1.95
vs -0.14

Q2.24

arrow
arrow

N/A

-1.35
vs -0.14

Q3.24

arrow
arrow

N/A

-0.99
vs -1.65

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

NA

8.9K  vs NA

Q1.23

arrow
arrow

NA

100.7K  vs NA

Q2.23

arrow
arrow

NA

141.2K  vs NA

Q3.23

arrow
arrow

NA

245.2K  vs NA

Q4.23

arrow
arrow

+2634%

244.4K  vs 8.9K

Q1.24

arrow
arrow

+113%

214.1K  vs 100.7K

Q2.24

arrow
arrow

+16%

163.2K  vs 141.2K

Q3.24

arrow
arrow

-46%

133.4K  vs 245.2K

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-110%

-1.10
vs -1.18

Q1.23

arrow
arrow

-67%

-0.67
vs -1.10

Q2.23

arrow
arrow

-76%

-0.76
vs -0.67

Q3.23

arrow
arrow

-133%

-1.33
vs -0.76

Q4.23

arrow
arrow

-331%

-3.31
vs -1.33

Q1.24

arrow
arrow

+247%

2.47
vs -3.31

Q2.24

arrow
arrow

-17%

-0.17
vs 2.47

Q3.24

arrow
arrow

-15%

-0.15
vs -0.17

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News

MGRX

globenewswire.com

8 hours ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
MGRX

newsfilecorp.com

8 hours ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
MGRX

globenewswire.com

8 hours ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
MGRX

globenewswire.com

17 hours ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
MGRX

globenewswire.com

17 hours ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
MGRX

globenewswire.com

17 hours ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN